Skip to main content
Caplight Logo









RhythmScience Inc.

RhythmScience Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.rhythm360.io/

Last Round

Series A

Mar 24, 2023

Total Funding Raised

$6M

Company Overview

RhythmScience Inc. is a health-tech company that provides a platform, Rhythm360, which analyzes cardiac data to improve the management of hypertension, heart failure, and rhythm disorders.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, EHR & EMR, Healthcare Analytics, Health IoT, Revenue Cycle

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

cardiac data managementremote cardiac monitoringvendor-neutral platformremote patient monitoringRPMEHR integrationcardiology softwareCIED managementCPT code automationcardiology workflow automationAI alert triageheart failure managementhealth data aggregationdigital health platformhealth IoTSOC 2 certified

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RhythmScience Inc. Comparables

Compare RhythmScience Inc. with similar companies based on industry and business-model similarity.

RhythmScience Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PaceMate
91%
Vector Remote Care
91%
Octagos Health
86%

RhythmScience Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 24, 2023
AcceleratorJan 25, 2022

RhythmScience Inc. Investors

Notable investors and investment history

RhythmScience Inc. investors
InvestorRounds
TenOneTen VenturesSeries A
Cedars Sinai Health VenturesSeries A
OCA VenturesSeries A
MATTERAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 228% MoM, reaching 26.8K.

  • Dec 21, 2023

    Grew 17% QoQ, from 35 to 41 employees.

RhythmScience Inc. Filings

Explore SEC and related filing metadata, where available.

RhythmScience Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RhythmScience Inc.'s valuation, stock price, and market status.

Is RhythmScience Inc. a public or private company?

RhythmScience Inc. is a private company.

What is the current stock price of RhythmScience Inc.?

RhythmScience Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is RhythmScience Inc. worth (valuation)?

Valuation information for RhythmScience Inc. is not publicly available.

Can I buy RhythmScience Inc. stock?

RhythmScience Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RhythmScience Inc.'s last funding round?

RhythmScience Inc.'s most recent funding round was Series A on March 24, 2023.

Who are the main investors in RhythmScience Inc.?

Key investors in RhythmScience Inc. include Cedars Sinai Health Ventures.

Will RhythmScience Inc. IPO soon?

No public IPO plans have been announced for RhythmScience Inc..

How can I track RhythmScience Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RhythmScience Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range54
Year Founded2019
Last FundingMar 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?